Xuebijing protects rats from sepsis challenged with Acinetobacter baumannii by promoting annexin A1 expression and inhibiting proinflammatory cytokines secretion

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  He, Xian Di ^a   Wang, Yan ^a   Wu, Qiong ^a   Wang, Hua Xue ^a   Chen, Zhen Dong ^a   Zheng, Rong Sheng ^a   Wang, Zi Shu ^a   Wang, Jun Bin ^a   Yang, Yan ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893746409     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/804940     Document Type: Article

References (48)

1. Vila J., Pachón J., Therapeutic options for Acinetobacter baumannii infections. Expert Opinion on Pharmacotherapy 2008 9 4 587 599 2-s2.0-40649109539 10.1517/14656566.9.4.587 (Pubitemid 351425386)
2. Aguirre-Ávalos G., Mijangos-Méndez J. C., Zavala-Silva M. L., Coronado-Magaña H., Amaya-Tapia G., Acinetobacter baumannii blood infections in intensive care patients. Gaceta Medica de Mexico 2009 145 1 21 25 2-s2.0-67249140285
3. Wang H., Guo P., Sun H., Wang H., Yang Q., Chen M., Xu Y., Zhu Y., Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese Hospitals. Antimicrobial Agents and Chemotherapy 2007 51 11 4022 4028 2-s2.0-35848934391 10.1128/AAC.01259-06 (Pubitemid 350057801)
4. Wisplinghoff H., Bischoff T., Tallent S. M., Seifert H., Wenzel R. P., Edmond M. B., Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases 2004 39 3 309 317 2-s2.0-3943093972 10.1086/421946 (Pubitemid 39050477)
5. Christaki E., Anyfanti P., Opal S. M., Immunomodulatory therapy for sepsis: an update. Expert Review of Anti-Infective Therapy 2011 9 11 1013 1033 2-s2.0-80155177917 10.1586/eri.11.122
6. Glauser M. P., Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Critical Care Medicine 2000 28 9 S4 S8 2-s2.0-0033810383
7. Tamayo E., Fernández A., Almansa R., Carrasco E., Heredia M., Lajo C., Goncalves L., Gómez-Herreras J. I., de Lejarazu R. O., Bermejo-Martin J. F., Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. European Cytokine Network 2011 22 2 82 87 2-s2.0-79961015817 10.1684/ecn.2011.0281
8. Novotny A. R., Reim D., Assfalg V., Altmayr F., Friess H. M., Emmanuel K., Holzmann B., Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology 2012 217 6 616 621 2-s2.0-84860237238 10.1016/j.imbio.2011.10.019
9. Osuchowski M. F., Welch K., Siddiqui J., Remick D. G., Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. Journal of Immunology 2006 177 3 1967 1974 2-s2.0-33746190736 (Pubitemid 44092537)
10. Kellum J. A., Kong L., Fink M. P., Weissfeld L. A., Yealy D. M., Pinsky M. R., Fine J., Krichevsky A., Delude R. L., Angus D. C., Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Archives of Internal Medicine 2007 167 15 1655 1663 2-s2.0-34548022149 10.1001/archinte.167.15.1655 (Pubitemid 47280347)
11. Iba T., Okamoto K., Kawasaki S., Nakarai E., Miyasho T., Effect of hemoperfusion using polymyxin B-immobilized fibers on non-shock rat sepsis model. Journal of Surgical Research 2011 171 2 755 761 2-s2.0-81155138901 10.1016/j.jss.2010.04.058
12. Friedman G., Jankowski S., Marchant A., Goldman M., Kahn R. J., Vincent J. L., Blood interleukin 10 levels parallel the severity of septic shock. Journal of Critical Care 1997 12 4 183 187 2-s2.0-0031445867 10.1016/S0883-9441(97)90030-7 (Pubitemid 28051044)
13. Gardlund B., Sjolin J., Nilsson A., Roll M., Wickerts C.-J., Wretlind B., Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. Journal of Infectious Diseases 1995 172 1 296 301 2-s2.0-0029038728
14. Zhang S.-W., Sun C.-D., Wen Y., Yin C.-H., Effect of treatment with Xuebijing injection on serum inflammatory mediators and Th1/2 of spleen in rats with sepsis. Chinese Critical Care Medicine 2006 18 11 673 676 2-s2.0-37849188151 (Pubitemid 44823441)
15. Li Y. P., Qiao Y. J., Wu Z. X., Effects of Xuebijing injection on protein C and tumor necrosis factor-alpha mRNA in rats with sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007 19 8 488 491
16. Xu D.-M., Ma X.-H., Ai Y.-H., Effect of Xuebijing injection pretreatment on expression of pulmonary surfactant-associated protein a in rat alveolar type II epithelial cells induced by lipopolysaccharide. Chinese Critical Care Medicine 2009 21 11 690 691 2-s2.0-73349088130 10.3760/cma.j.issn.1003-0603. 2009.11.019
17. Sun J., Xue Q., Guo L., Cui L., Wang J., Xuebijing protects against lipopolysaccharide-induced lung injury in rabbits. Experimental Lung Research 2010 36 4 211 218 2-s2.0-77951831568 10.3109/01902140903312123
18. Cirioni O., Silvestri C., Ghiselli R., Orlando F., Riva A., Gabrielli E., Mocchegiani F., Cianforlini N., Trombettoni M. M. C., Saba V., Scalise G., Giacometti A., Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis. Critical Care Medicine 2009 37 4 1403 1407 2-s2.0-67650480375 10.1097/CCM.0b013e31819c3e22
19. He X. D., Zou Q., Chen Z. D., Yan E. P., Proteomic analysis of neutrophils of rats with Acinetobacter baumannii sepsis. Chinese Journal of Microbiology and Immunology 2012 32 5 385 394 10.3760/cma.j.issn.0254-5101.2012. 05.001
20. Breslow J. M., Meissler J. Jr., Hartzell R. R., Spence P. B., Truant A., Gaughan J., Eisenstein T. K., Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance. Infection and Immunity 2011 79 8 3317 3327 2-s2.0-79961101463 10.1128/IAI.00069-11
21. Rodríguez-Hernández M.-J., Jiménez-Mejias M. E., Pichardo C., Cuberos L., García-Curiel A., Pachón J., Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis. Clinical Microbiology and Infection 2004 10 6 581 584 2-s2.0-3242722317 10.1111/j.1469-0691.2004.00910.x (Pubitemid 38961588)
22. Hu Z., Sayeed M. M., Activation of PI3-kinase/PKB contributes to delay in neutrophil apoptosis after thermal injury. American Journal of Physiology-Cell Physiology 2005 288 5 C1171 C1178 2-s2.0-17644368966 10.1152/ajpcell.00312.2004 (Pubitemid 40559392)
23. Mulligan M. S., Varani J., Dame M. K., Lane C. L., Smith C. W., Anderson D. C., Ward P. A., Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. The Journal of Clinical Investigation 1991 88 4 1396 1406 2-s2.0-0025951155
24. Yang Y., Cao M.-H., Wang Q., Yuan D.-D., Li L., Tao L., The effects of 2-aminoethoxydiphenyl borate and diphenylboronic anhydride on gap junctions composed of connexin43 in TM4 sertoli cells. Biological and Pharmaceutical Bulletin 2011 34 9 1390 1397 2-s2.0-80052481745 10.1248/bpb.34.1390
25. Hong X., Wang Q., Yang Y., Zheng S., Tong X., Zhang S., Tao L., Harris A. L., Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin. Cancer Letters 2012 317 2 165 171 2-s2.0-84856625041 10.1016/j.canlet.2011.11.019
26. Hongsrichan N., Rucksaken R., Chamgramol Y., Annexin A1: a new immunohistological marker of cholangiocarcinoma. World Journal of Gastroenterology 2013 19 16 2456 2465 10.3748/wjg.v19.i16.2456
27. Kurt A. N. C., Aygun A. D., Godekmerdan A., Kurt A., Dogan Y., Yilmaz E., Serum IL-1 β IL-6, IL-8, and TNF- α levels in early diagnosis and management of neonatal sepsis. Mediators of Inflammation 2007 2007 5 31397 10.1155/2007/31397 2-s2.0-44049107587
28. Waage A., Halstensen A., Espevik T., Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. The Lancet 1987 1 8529 355 357 2-s2.0-0023094408 (Pubitemid 17010024)
29. Rescher U., Gerke V., Annexins-unique membrane binding proteins with diverse functions. Journal of Cell Science 2004 117 13 2631 2639 2-s2.0-3242877433 10.1242/jcs.01245 (Pubitemid 38997247)
30. Gavins F. N. E., Yona S., Kamal A. M., Flower R. J., Perretti M., Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 2003 101 10 4140 4147 2-s2.0-0037588978 10.1182/blood-2002-11-3411 (Pubitemid 36857897)
31. Goulding N. J., Euzger H. S., Butt S. K., Perretti M., Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation. Inflammation Research 1998 47 supplement 3 S158 S165 2-s2.0-0031727193 (Pubitemid 28493021)
32. 2+ signalling to membrane dynamics. Nature Reviews Molecular Cell Biology 2005 6 6 449 461 2-s2.0-20344369564 10.1038/nrm1661 (Pubitemid 40780557)
33. Williams S. L., Milne I. R., Bagley C. J., Gamble J. R., Vadas M. A., Pitson S. M., Khew-Goodall Y., A proinflammatory role for proteolytically cleaved annexin A1 in neutrophil transendothelial migration. Journal of Immunology 2010 185 5 3057 3063 2-s2.0-78049395345 10.4049/jimmunol.1000119
34. Scannell M., Maderna P., Lipoxins and annexin-1: resolution of inflammation and regulation of phagocytosis of apoptotic cells. TheScientificWorldJOURNAL 2006 6 1555 1573 2-s2.0-33845498862 10.1100/tsw.2006.259 (Pubitemid 44915983)
35. Minghetti L., Nicolini A., Polazzi E., Greco A., Perretti M., Parente L., Levi G., Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocartin 1. British Journal of Pharmacology 1999 126 6 1307 1314 2-s2.0-0032996598 (Pubitemid 29142060)
36. Ferlazzo V., D'Agostino P., Milano S., Caruso R., Feo S., Cillari E., Parente L., Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis. International Immunopharmacology 2003 3 10-11 1363 1369 2-s2.0-0042928398 10.1016/S1567-5769(03)00133-4 (Pubitemid 37025717)
37. Ware L. B., Matthay M. A., The acute respiratory distress syndrome. The New England Journal of Medicine 2000 342 18 1334 1349 2-s2.0-0034604129 10.1056/NEJM200005043421806 (Pubitemid 30408719)
38. da Cunha E. E., Oliani S. M., Damazo A. S., Effect of annexin-A1 peptide treatment during lung inflammation induced by lipopolysaccharide. Pulmonary Pharmacology and Therapeutics 2012 25 4 303 311 2-s2.0-84860595820 10.1016/j.pupt.2012.04.002
39. Gavins F. N., Hickey M. J., Annexin A1 and the regulation of innate and adaptive immunity. Frontiers in Immunology 2012 3, article 354 10.3389/fimmu.2012.00354
40. Tsai W. H., Shih C. H., Yu Y. B., Hsu H. C., Plasma levels in sepsis patients of annexin A1, lipoxin A4, macrophage inflammatory protein-3a, and neutrophil gelatinase-associated lipocalin. Journal of the Chinese Medical Association 2013 76 9 486 490 10.1016/j.jcma.2013.05.004
41. Kosicka A., Cunliffe A. D., Mackenzie R., Attenuation of plasma annexin A1 in human obesity. The FASEB Journal 2013 27 1 368 378 10.1096/fj.12-213728
42. Adib-Conquy M., Cavaillon J.-M., Compensatory anti-inflammatory response syndrome. Thrombosis and Haemostasis 2009 101 1 36 47 2-s2.0-60849114014 10.1160/TH08-07-0421
43. Muenzer J. T., Davis C. G., Chang K., Schmidt R. E., Dunne W. M., Coopersmith C. M., Hotchkiss R. S., Characterization and modulation of the immunosuppressive phase of sepsis. Infection and Immunity 2010 78 4 1582 1592 2-s2.0-77950208700 10.1128/IAI.01213-09
44. Wang Q., Yao Y.-M., Wang W.-J., Xian L.-M., Dong N., Xu S., Dou K.-F., Effect of Xuebijing injection on renal high mobility group box-1 protein expression and acute kidney injury in rats scald injury. Acta Academiae Medicinae Sinicae 2007 29 4 478 483 2-s2.0-34648820078 (Pubitemid 47455189)
45. Qi F., Liang Z.-X., She D.-Y., Yan G.-T., Chen L.-A., A clinical study on the effects and mechanism of Xuebijing injection in severe pneumonia patients. Journal of Traditional Chinese Medicine 2011 31 1 46 49 2-s2.0-79956104011
46. Zhang P., Cao S. H., Cui K. L., Wang J. D., The influences of Xuebijing on the expression of human leukocyte antigen-DR on monocytes in patients with multiple organ dysfunction syndrome. Zhong Guo Zhong Xi Yi Jie He Za Zhi 2002 9 1 21 23
47. Blackwell T. S., Christman J. W., Sepsis and cytokines: current status. British Journal of Anaesthesia 1996 77 1 110 117 2-s2.0-0029944101 (Pubitemid 26229918)
48. Yeh F. L., Shen H. D., Fang R. H., Deficient transforming growth factor β and interleukin-10 responses contribute to the septic death of burned patients. Burns 2002 28 7 631 637 2-s2.0-0036844538 10.1016/S0305-4179(02)00113- 4 (Pubitemid 35292546)